Genotropin
ApprovedSmall molecule
PfizerGenotropin is one of 194 small molecule programs targeting Small for gestational age. It is currently in Approved.
8
Indications
23
Total Trials
1
Active Trials
193
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
364 competitors in Growth
#DrugCompanyPhaseTrials
1Genotropin
PfizerApproved
Genotropin
EMD SeronoPreclinical
Lovenox
SanofiPreclinical
Lenvima
EisaiPreclinical
Zolymbus
AbbViePreclinical
Zyloprim
Alnylam PharmaceuticalsPreclinical
Herceptin
OOrganon and Co
Preclinical
Somavaratan
Novo NordiskPreclinical
Glucophage
EMD SeronoPreclinical
Trental
VValidus Pharmaceuticals
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Growth Hormone Deficiency6 trials
Show 3 more trials
Growth5 trials
Small for gestational age3 trials
Efficacy and Safety2 trials
6 more indications
Prader-Willi syndrome1 trial
Juvenile Idiopathic Arthritis1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Genotropin. EMBL-EBI & Wellcome Sanger Institute.
- [4]